Senior Manager, Medical Learning at Bristol-Myers Squibb

Kariya-shi, Aichi, Japan

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

BA/BS required. MBA, PhD, PharmD, Nursing degree or other graduate experience strongly preferred
5+ years pharmaceutical experience, including professional work experience in medical learning
Excellent level of English
Strong knowledge of Medical Affairs’ role & responsibilities, including field & office-based teams
Knowledge of adult learning principles, learning design & executing learning strategies preferred
Demonstrated ability to work effectively with matrix teams
High level of digital agility
Strong Communication, organizational and interpersonal skills
Excellent facilitation and presentation skills
Ability to prioritize, manage and execute on multiple projects

Responsibilities

Collaborate with key stakeholders (Country Medical Director, Business Unit Medical leads) to identify all medical learning needs and deliver high-quality scientific, skill and capability-based pathways, including design, development and integration of content related to market strategy
Develop a learning strategy that supports local business objectives
Continuously seek to identify and leverage state-of-the-art adult learning methodologies to accelerate skill and knowledge development
Leverage key worldwide commercialization learning and WW Medical learning initiatives at the market level; collaborate with Learning managers in other markets to share learning
Develop and monitor metrics to evaluate the success of training, ensuring impact meets business needs
Partner with WW Medical Learning to coordinate and execute scientific and soft skills onboarding programs for new medical team members
Develop, collaborate and deliver all ongoing Medical Learning programmes across Therapeutic Areas for all in-market medical team members
Collaborate with WW/IM Medical Learning to lead planning/execution of scientific learning initiatives to ensure medical launch readiness
Collaborate with local Business unit leads and WW Medical Learning to develop appropriate field readiness validation programmes
Act as a strategic business partner across Japan to provide innovative and flexible learning solutions that drive an evolving and agile organisation

Skills

Medical Learning

Learning Strategy

Stakeholder Collaboration

Content Design

Scientific Training

Capability Development

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free